Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -137,125 | -83,352 | 11,366 | 19,984 | -20,269 |
| Depreciation Amortization | 5,245 | 3,692 | 2,858 | 2,133 | 1,553 |
| Accounts receivable | 252 | 353 | 293 | -955 | 798 |
| Accounts payable and accrued liabilities | 10,763 | -1,773 | 2,017 | 1,437 | -1,824 |
| Other Working Capital | 21,727 | 11,356 | -66,124 | -35,775 | -12,998 |
| Other Operating Activity | -1,568 | 6,109 | 365 | 1,855 | 3,094 |
| Operating Cash Flow | $-100,706 | $-63,615 | $-49,225 | $-11,321 | $-29,646 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -329,568 | -211,804 | -108,127 | -31,642 | -93,911 |
| PPE Investments | -1,629 | -933 | -362 | -1,477 | -2,390 |
| Sale Of Investment | 192,045 | 92,001 | 40,687 | 59,829 | 91,436 |
| Other Investing Activity | 0 | 0 | 0 | 6,000 | 0 |
| Investing Cash Flow | $-139,152 | $-120,736 | $-67,802 | $32,710 | $-4,865 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -2,598 | -6,667 |
| Common Stock Issued | 180,163 | 254,394 | 317 | 167 | 176 |
| Common Stock Repurchased | N/A | N/A | N/A | -51 | -1 |
| Other Financing Activity | -564 | -5,883 | 0 | 96,700 | 0 |
| Financing Cash Flow | $179,599 | $248,511 | $317 | $94,218 | $-6,492 |
| Beginning Cash Position | 117,773 | 53,613 | 170,323 | 54,716 | 95,719 |
| End Cash Position | 57,514 | 117,773 | 53,613 | 170,323 | 54,716 |
| Net Cash Flow | $-60,259 | $64,160 | $-116,710 | $115,607 | $-41,003 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,706 | -63,615 | -49,225 | -11,321 | -29,646 |
| Capital Expenditure | -1,629 | -933 | -362 | -1,477 | -2,390 |
| Free Cash Flow | -102,335 | -64,548 | -49,587 | -12,798 | -32,036 |